From the Journals

Phosphodiesterase-5 inhibitors often prescribed inappropriately

Publish date: March 9, 2018

 

FROM ANNALS OF THE AMERICAN THORACIC SOCIETY

SOURCE: Wiener RS et al. Ann Am Thorac Soc. 2018 Feb 27. doi: 10.1513/AnnalsATS.201710-762OC.

Pages

Recommended Reading

Award for best hospital goes to … the Mayo Clinic
MDedge Rheumatology
CANTOS sings of novel strategy for cardiovascular, cancer prevention
MDedge Rheumatology
Dr. Clyde Yancy: CANTOS wows, opens new therapeutic avenues
MDedge Rheumatology
Risk factors for pulmonary hypertension identified in lupus patients
MDedge Rheumatology
Riociguat may benefit subset of PAH patients
MDedge Rheumatology
Rheumatoid arthritis increases risk of COPD hospitalizations
MDedge Rheumatology
FDA recommends voluntary recall of Limbrel
MDedge Rheumatology
Testing for latent tuberculosis infection
MDedge Rheumatology
Lung scan often not requested for new SSc patients
MDedge Rheumatology
NIAID proposes 3-pronged plan for universal influenza vaccine
MDedge Rheumatology